The AJMC® Migraine compendium is a comprehensive resource for clinical news and expert insights for the recurring type of headache, which is accompanied by side effects.
April 20th 2023
This quantitative and qualitative analysis highlights differences in prior authorization requirements for migraine drugs from nearly 50 managed care organizations and summarizes broad types of criteria used.
Prochlorperzine Is More Effective for Treating Migraines in the ED Than Commonly Used Drugs
October 29th 2017Hydromorphone is commonly used in hospital emergency rooms to treat patients with migraines; however, the drug is less effective than the drug prochlorperazine used with diphenhydramine, according to research.
Read More
Looking Ahead at the Specialty Drug Pipeline After an Active Year of Approvals
October 17th 2017Aimee Tharaldson, PharmD, of Express Scripts kicked off the Academy of Managed Care Pharmacy (AMCP) 2017 Nexus, held October 16-19 in Dallas, Texas, with a presentation on the pipeline of specialty pharmaceuticals in development.
Read More
This study describes the patient characteristics and healthcare utilization of a chronic pain population within an integrated healthcare system in northern California.
Read More
Overuse of Brain Scans for Headaches Persists, Despite Guidelines
March 18th 2014Brain scans remain "substantially overused" on patients who visit the doctor complaining of headaches and migraines, despite multiple guidelines recommending against their use. Physicians must be vigilant about having conversations with patients about the risks, neurologists say.
Read More
Measuring Migraine-Related Quality of Care Across 10 Health Plans
Standardized measurement of migraine, an underdiagnosed and perhaps underrecognized condition, is necessary for health plans to understand utilization of costly diagnostic and treatment services.
Read More